{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:02:22Z","timestamp":1775181742071,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010605","name":"Office of Vice Chancellor for Research and Technology, University of Isfahan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25114-0","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:38:16Z","timestamp":1763725096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive multi-network analysis of ceRNAs and transcription factors for papillary thyroid carcinoma diagnosis and prognosis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-909X","authenticated-orcid":false,"given":"Seyede Elmira Yazdi","family":"Rouholamini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-2293","authenticated-orcid":false,"given":"Seyed-Morteza","family":"Javadirad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3095-6471","authenticated-orcid":false,"given":"Mohsen","family":"Kolahdouzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"25114_CR1","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/s41388-022-02499-0","volume":"41","author":"S Hong","year":"2022","unstructured":"Hong, S. et al. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. Oncogene 41, 5121\u20135132 (2022).","journal-title":"Oncogene"},{"key":"25114_CR2","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-17-0266","volume":"235","author":"MA Zaballos","year":"2017","unstructured":"Zaballos, M. A. & Santisteban, P. Key signaling pathways in thyroid cancer. J. Endocrinol. 235, R43\u2013R61 (2017).","journal-title":"J. Endocrinol."},{"key":"25114_CR3","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.3390\/cancers14174128","volume":"14","author":"EA Toraih","year":"2022","unstructured":"Toraih, E. A. et al. A miRNA-based prognostic model to trace thyroid cancer recurrence. Cancers 14, 4128 (2022).","journal-title":"Cancers"},{"key":"25114_CR4","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.1111\/jcmm.16799","volume":"25","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Comprehensive characterization of pathological stage-related genes of papillary thyroid cancer along with survival prediction. J. Cell. Mol. Med. 25, 8390\u20138404 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"25114_CR5","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1002\/cam4.4836","volume":"11","author":"R Liu","year":"2022","unstructured":"Liu, R. et al. A novel prognostic model for papillary thyroid cancer based on epithelial\u2013mesenchymal transition-related genes. Cancer Med. 11, 4703\u20134720 (2022).","journal-title":"Cancer Med."},{"key":"25114_CR6","doi-asserted-by":"crossref","unstructured":"Prete, A. et al. Update on Fundamental Mechanisms of Thyroid Cancer. Front. Endocrinol. (Lausanne). 11, (2020).","DOI":"10.3389\/fendo.2020.00102"},{"key":"25114_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: The rosetta stone of a hidden RNA language?. Cell 146, 353\u2013358 (2011).","journal-title":"Cell"},{"key":"25114_CR8","doi-asserted-by":"publisher","first-page":"20795","DOI":"10.1038\/s41598-023-47816-z","volume":"13","author":"A Shariatmadar Taleghani","year":"2023","unstructured":"Shariatmadar Taleghani, A., Zohrab Beigi, Y., Zare-Mirakabad, F. & Masoudi-Nejad, A. Exploring ceRNA networks for key biomarkers in breast cancer subtypes and immune regulation. Sci. Rep. 13, 20795 (2023).","journal-title":"Sci. Rep."},{"key":"25114_CR9","doi-asserted-by":"publisher","first-page":"112251","DOI":"10.1016\/j.biopha.2021.112251","volume":"146","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Khan, S., Li, L., ten Hagen, T. L. M. & Falahati, M. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view. Biomed. Pharmacother. 146, 112251 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"25114_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/bib\/bbz006","volume":"21","author":"X Qi","year":"2020","unstructured":"Qi, X., Lin, Y., Chen, J. & Shen, B. Decoding competing endogenous RNA networks for cancer biomarker discovery. Brief. Bioinform. 21, 441\u2013457 (2020).","journal-title":"Brief. Bioinform."},{"key":"25114_CR11","doi-asserted-by":"publisher","first-page":"17787","DOI":"10.1038\/s41598-022-22768-y","volume":"12","author":"Z Li","year":"2022","unstructured":"Li, Z., Zhou, J., Gu, L. & Zhang, B. Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer. Sci. Rep. 12, 17787 (2022).","journal-title":"Sci. Rep."},{"key":"25114_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jcmm.12952","volume":"21","author":"Y An","year":"2017","unstructured":"An, Y., Furber, K. L. & Ji, S. Pseudogenes regulate parental gene expression via ceRNA network. J. Cell. Mol. Med. 21, 185\u2013192 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"25114_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1515\/med-2021-0389","volume":"17","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma. Open Med. 17, 22\u201333 (2022).","journal-title":"Open Med."},{"key":"25114_CR14","first-page":"1","volume":"9","author":"D Xu","year":"2021","unstructured":"Xu, D. et al. The functional characterization of epigenetically related lncRNAs involved in dysregulated CeRNA\u2013CeRNA networks across eight cancer types. Front. Cell Dev. Biol. 9, 1\u20139 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"25114_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-018-0827-8","volume":"17","author":"Y Zhong","year":"2018","unstructured":"Zhong, Y. et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol. Cancer 17, 79 (2018).","journal-title":"Mol. Cancer"},{"key":"25114_CR16","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR17","doi-asserted-by":"publisher","first-page":"gkaf018","DOI":"10.1093\/nar\/gkaf018","volume":"53","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Chen, L., Lun, A. T. L., Baldoni, P. L. & Smyth, G. K. edgeR v4: Powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Res. 53, gkaf018 (2025).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR18","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"25114_CR19","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR20","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR21","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"25114_CR22","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.patter.2020.100052","volume":"1","author":"A Salavaty","year":"2020","unstructured":"Salavaty, A., Ramialison, M. & Currie, P. D. Integrated value of influence: An integrative method for the identification of the most influential nodes within networks. Patterns 1, 100052 (2020).","journal-title":"Patterns"},{"key":"25114_CR23","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"25114_CR24","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The SVA package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"25114_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nbt.3838","volume":"35","author":"L Collado-Torres","year":"2017","unstructured":"Collado-Torres, L. et al. Reproducible RNA-seq analysis using recount2. Nat. Biotechnol. 35, 319\u2013321 (2017).","journal-title":"Nat. Biotechnol."},{"key":"25114_CR27","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. MiRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 48, D127\u2013D131 (2020).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR28","doi-asserted-by":"publisher","first-page":"D326","DOI":"10.1093\/nar\/gkab997","volume":"50","author":"J Kang","year":"2022","unstructured":"Kang, J. et al. RNAInter v40: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 50, D326\u2013D332 (2022).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR29","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang, H. Y. et al. MiRTarBase update 2022: An informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 50, D222\u2013D230 (2022).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR30","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. Mirwalk: An online resource for prediction of microrna binding sites. PLoS ONE 13, e0206239 (2018).","journal-title":"PLoS ONE"},{"key":"25114_CR31","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. StarBase v20: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92\u2013D97 (2014).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/bioinformatics\/bts344","volume":"28","author":"A Jeggari","year":"2012","unstructured":"Jeggari, A., Marks, D. S. & Larsson, E. miRcode: A map of putative microrna target sites in the long non-coding transcriptome. Bioinformatics 28, 2062\u20132063 (2012).","journal-title":"Bioinformatics"},{"key":"25114_CR33","doi-asserted-by":"publisher","first-page":"W435","DOI":"10.1093\/nar\/gkx279","volume":"45","author":"M Mann","year":"2017","unstructured":"Mann, M., Wright, P. R. & Backofen, R. IntaRNA 20: Enhanced and customizable prediction of RNA-RNA interactions. Nucleic Acids Res. 45, W435\u2013W439 (2017).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR34","unstructured":"Jr, H. Hmisc: Harrell Miscellaneous. https:\/\/github.com\/harrelfe\/hmisc. (2025)."},{"key":"25114_CR35","unstructured":"Wei, A. T. Visualization of a correlation matrix: Package \u2018 corrplot \u2018. CRAN: Contributed Packages https:\/\/cran.r-project.org\/web\/packages\/corrplot\/corrplot.pdf (2015)."},{"key":"25114_CR36","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR37","doi-asserted-by":"publisher","first-page":"e0164535","DOI":"10.1371\/journal.pone.0164535","volume":"11","author":"F Vafaee","year":"2016","unstructured":"Vafaee, F. et al. ORTI: An open-access repository of transcriptional interactions for interrogating mammalian gene expression data. PLoS ONE 11, e0164535 (2016).","journal-title":"PLoS ONE"},{"key":"25114_CR38","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/sim.70050","volume":"44","author":"O Efthimiou","year":"2025","unstructured":"Efthimiou, O. et al. Measuring the performance of survival models to personalize treatment choices. Stat. Med. 44, e70050 (2025).","journal-title":"Stat. Med."},{"key":"25114_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/bib\/bbr001","volume":"12","author":"RM Simon","year":"2011","unstructured":"Simon, R. M., Subramanian, J., Li, M. C. & Menezes, S. Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief. Bioinform. 12, 203\u2013214 (2011).","journal-title":"Brief. Bioinform."},{"key":"25114_CR40","unstructured":"Kassambara, A., Marcin Kosinski, M., Biecek, P. & Fabian, S. Package \u2018survminer \u2018 - Drawing Survival Curves using \u2018ggplot2 \u2018. https:\/\/rpkgs.datanovia.com\/survminer\/index.html. (2024)."},{"key":"25114_CR41","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397 (2013).","journal-title":"Stat. Med."},{"key":"25114_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).","journal-title":"BMC Bioinformatics"},{"key":"25114_CR43","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179\u2013e179 (2005).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","volume":"13","author":"DB Dudekula","year":"2016","unstructured":"Dudekula, D. B. et al. Circinteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 13, 34\u201342 (2016).","journal-title":"RNA Biol."},{"key":"25114_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12859-022-04705-y","volume":"23","author":"S Zhong","year":"2022","unstructured":"Zhong, S. & Feng, J. CircPrimer 2.0: A software for annotating circRNAs and predicting translation potential of circRNAs. BMC Bioinformatics 23, 215 (2022).","journal-title":"BMC Bioinformatics"},{"key":"25114_CR46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/cbic.201900514","volume":"21","author":"M Boss","year":"2020","unstructured":"Boss, M. & Arenz, C. A fast and easy method for specific detection of circular RNA by rolling-circle amplification. ChemBioChem 21, 793\u2013796 (2020).","journal-title":"ChemBioChem"},{"key":"25114_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"25114_CR48","doi-asserted-by":"publisher","first-page":"45e","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 45e\u2013445 (2001).","journal-title":"Nucleic Acids Res."},{"key":"25114_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.omtn.2021.04.019","volume":"24","author":"DD Zhang","year":"2021","unstructured":"Zhang, D. D. et al. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma. Mol. Ther. Nucleic Acids 24, 1033\u20131050 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"25114_CR50","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41467-019-09649-1","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat. Commun. 10, 1637 (2019).","journal-title":"Nat. Commun."},{"key":"25114_CR51","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1038\/s41598-022-14732-7","volume":"12","author":"L Li","year":"2022","unstructured":"Li, L. et al. Construction of a four-mRNA prognostic signature with its ceRNA network in CESC. Sci. Rep. 12, 10691 (2022).","journal-title":"Sci. Rep."},{"key":"25114_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11080868","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y. et al. Identification of circrna-lncrna-mirna-mrna competitive endogenous rna network as novel prognostic markers for acute myeloid leukemia. Genes 11, 1\u201318 (2020).","journal-title":"Genes"},{"key":"25114_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2022.1002186","volume":"12","author":"H Li","year":"2023","unstructured":"Li, H. et al. Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer. Front. Oncol. 12, 1\u201314 (2023).","journal-title":"Front. Oncol."},{"key":"25114_CR54","doi-asserted-by":"publisher","first-page":"144608","DOI":"10.1016\/j.gene.2020.144608","volume":"744","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target. Gene 744, 144608 (2020).","journal-title":"Gene"},{"key":"25114_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yexcr.2017.06.014","volume":"358","author":"L Liu","year":"2017","unstructured":"Liu, L. et al. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin\/TCF signaling. Exp. Cell Res. 358, 209\u2013216 (2017).","journal-title":"Exp. Cell Res."},{"key":"25114_CR56","first-page":"5259","volume":"24","author":"ZH Xuan","year":"2020","unstructured":"Xuan, Z. H. et al. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3. Eur. Rev. Med. Pharmacol. Sci. 24, 5259\u20135266 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"25114_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/ol.2021.13181","volume":"23","author":"Y Cai","year":"2022","unstructured":"Cai, Y. & Yang, W. PKMYT1 regulates the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma cells by targeting CCNA2. Oncol. Lett. 23, 63 (2022).","journal-title":"Oncol. Lett."},{"key":"25114_CR58","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.2147\/OTT.S255746","volume":"13","author":"QY Zhang","year":"2020","unstructured":"Zhang, Q. Y., Chen, X. Q., Liu, X. C. & Wu, D. M. PKMYT1 promotes gastric cancer cell proliferation and apoptosis resistance. Onco. Targets. Ther. 13, 7747\u20137757 (2020).","journal-title":"Onco. Targets. Ther."},{"key":"25114_CR59","first-page":"253","volume":"13","author":"T Zhu","year":"2021","unstructured":"Zhu, T., Lou, Q., Shi, Z. & Chen, G. Identification of key miRNA-gene pairs in gastric cancer through integrated analysis of mRNA and miRNA microarray. Am. J. Transl. Res. 13, 253\u2013269 (2021).","journal-title":"Am. J. Transl. Res."},{"key":"25114_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0185558","volume":"12","author":"EE Cilek","year":"2017","unstructured":"Cilek, E. E., Ozturk, H. & Dedeoglu, B. G. Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines. PLoS ONE 12, 1\u201321 (2017).","journal-title":"PLoS ONE"},{"key":"25114_CR61","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.3389\/fonc.2020.571524","volume":"10","author":"Z Yu","year":"2021","unstructured":"Yu, Z., Zou, H., Wang, H., Li, Q. & Yu, D. Identification of key gene signatures associated with bone metastasis in castration-resistant prostate cancer using co-expression analysis. Front. Oncol. 10, 571524 (2021).","journal-title":"Front. Oncol."},{"key":"25114_CR62","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.3892\/ol.2018.8296","volume":"15","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-seq data. Oncol. Lett. 15, 4550\u20134556 (2018).","journal-title":"Oncol. Lett."},{"key":"25114_CR63","doi-asserted-by":"publisher","first-page":"11680","DOI":"10.3748\/wjg.v21.i41.11680","volume":"21","author":"LL Guo","year":"2015","unstructured":"Guo, L. L. et al. Competing endogenous RNA networks and gastric cancer. World J. Gastroenterol. 21, 11680\u201311687 (2015).","journal-title":"World J. Gastroenterol."},{"key":"25114_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12920-021-00918-x","volume":"14","author":"L Gao","year":"2021","unstructured":"Gao, L., Zhao, Y., Ma, X. & Zhang, L. Integrated analysis of lncRNA\u2013miRNA\u2013mRNA ceRNA network and the potential prognosis indicators in sarcomas. BMC Med. Genomics 14, 67 (2021).","journal-title":"BMC Med. Genomics"},{"key":"25114_CR65","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3892\/ol.2020.11809","volume":"20","author":"X Yang","year":"2020","unstructured":"Yang, X., Xie, Z., Lei, X. & Gan, R. Long non-coding RNA GAS5 in human cancer (Review). Oncol. Lett. 20, 2587\u20132594 (2020).","journal-title":"Oncol. Lett."},{"key":"25114_CR66","doi-asserted-by":"publisher","first-page":"18312","DOI":"10.1038\/s41598-022-21492-x","volume":"12","author":"S Gupta","year":"2022","unstructured":"Gupta, S., Panda, P. K., Luo, W., Hashimoto, R. F. & Ahuja, R. Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer. Sci. Rep. 12, 18312 (2022).","journal-title":"Sci. Rep."},{"key":"25114_CR67","first-page":"1","volume":"12","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. LncRNA GAS5 represses stemness and malignancy of gliomas via elevating the SPACA6-miR-125a\/let-7e Axis. Front. Oncol. 12, 1\u201315 (2022).","journal-title":"Front. Oncol."},{"key":"25114_CR68","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/CMAR.S189052","volume":"11","author":"J Ji","year":"2019","unstructured":"Ji, J., Dai, X., Yeung, S. C. J. & He, X. The role of long non-coding RNA GAS5 in cancers. Cancer Manag. Res. 11, 2729\u20132737 (2019).","journal-title":"Cancer Manag. Res."},{"key":"25114_CR69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/CBM-190505","volume":"29","author":"JY Song","year":"2020","unstructured":"Song, J. Y. et al. A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer. Cancer Biomark. 29, 493\u2013508 (2020).","journal-title":"Cancer Biomark."},{"key":"25114_CR70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ncrna8030039","volume":"8","author":"J Kaur","year":"2022","unstructured":"Kaur, J. et al. Tumor suppressive effects of GAS5 in cancer cells. Non-coding RNA 8, 39 (2022).","journal-title":"Non-coding RNA"},{"key":"25114_CR71","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wu, S., Yang, X., Li, X. & Chen, R. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer. Biosci. Rep. 39, (2019).","DOI":"10.1042\/BSR20190091"},{"key":"25114_CR72","doi-asserted-by":"publisher","first-page":"11471","DOI":"10.1002\/jcb.28425","volume":"120","author":"F Shams","year":"2019","unstructured":"Shams, F. & Ghorbian, S. Evaluation of prognostic usefulness of long noncoding RNA GAS5 and FAL1 in papillary thyroid carcinoma. J. Cell. Biochem. 120, 11471\u201311477 (2019).","journal-title":"J. Cell. Biochem."},{"key":"25114_CR73","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10147-023-02400-3","volume":"28","author":"L Dai","year":"2023","unstructured":"Dai, L. et al. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer. Int. J. Clin. Oncol. 28, 1461\u20131474 (2023).","journal-title":"Int. J. Clin. Oncol."},{"key":"25114_CR74","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.2147\/OTT.S316292","volume":"14","author":"C Lv","year":"2021","unstructured":"Lv, C. et al. Expression profiles of circular rnas in human papillary thyroid carcinoma based on rna deep sequencing. Onco. Targets. Ther. 14, 3821\u20133832 (2021).","journal-title":"Onco. Targets. Ther."},{"key":"25114_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10238-021-00742-8","volume":"22","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma. Clin. Exp. Med. 22, 229\u2013243 (2022).","journal-title":"Clin. Exp. Med."},{"key":"25114_CR76","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12885-023-10655-2","volume":"23","author":"HW Tsai","year":"2023","unstructured":"Tsai, H. W., Cheng, S. W., Chen, C. C., Chen, I. W. & Ho, C. L. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt\/\u03b2-catenin signaling target gene related to hepatocellular carcinoma. BMC Cancer 23, 1025 (2023).","journal-title":"BMC Cancer"},{"key":"25114_CR77","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1002\/cam4.5533","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. RMI2 is a novel prognostic and predictive biomarker for breast cancer. Cancer Med. 12, 8331\u20138350 (2023).","journal-title":"Cancer Med."},{"key":"25114_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.762946","volume":"11","author":"W Ren","year":"2021","unstructured":"Ren, W. et al. miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression. Front. Oncol. 11, 762946 (2021).","journal-title":"Front. Oncol."},{"key":"25114_CR79","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bcpt.13641","volume":"129","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. Apatinib combined with keytruda treatment induces apoptosis of gastric carcinoma cells through CES4\/miR-616-5p\/DUSP2 axis. Basic Clin. Pharmacol. Toxicol. 129, 345\u2013356 (2021).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"25114_CR80","doi-asserted-by":"publisher","first-page":"e0116979","DOI":"10.1371\/journal.pone.0116979","volume":"10","author":"XT Zhang","year":"2015","unstructured":"Zhang, X. T. et al. Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis. PLoS ONE 10, e0116979 (2015).","journal-title":"PLoS ONE"},{"key":"25114_CR81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2162-3619-1-18","volume":"1","author":"J-J Hung","year":"2012","unstructured":"Hung, J.-J., Hsueh, C.-T., Chen, K.-H., Hsu, W.-H. & Wu, Y.-C. Clinical significance of E2F1 protein expression in non-small cell lung cancer. Exp. Hematol. Oncol. 1, 18 (2012).","journal-title":"Exp. Hematol. Oncol."},{"key":"25114_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7081611","volume":"2022","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Transcription factor E2F1 exacerbates papillary thyroid carcinoma cell growth and invasion via upregulation of LINC00152. Anal. Cell. Pathol. 2022, 1\u201310 (2022).","journal-title":"Anal. Cell. Pathol."},{"key":"25114_CR83","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10038-004-0146-3","volume":"49","author":"M Onda","year":"2004","unstructured":"Onda, M. et al. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers. J. Hum. Genet. 49, 312\u2013318 (2004).","journal-title":"J. Hum. Genet."},{"key":"25114_CR84","first-page":"1979","volume":"22","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Li, S. Y. & Zhang, L. B. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 22, 1979\u20131986 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"25114_CR85","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.1038\/s41598-022-16541-4","volume":"12","author":"L Qi","year":"2022","unstructured":"Qi, L., Ren, Z. & Li, W. E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma. Sci. Rep. 12, 12132 (2022).","journal-title":"Sci. Rep."},{"key":"25114_CR86","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.7150\/jca.53708","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. E2F4 promotes the proliferation of hepatocellular carcinoma cells through upregulation of CDCA3. J. Cancer 12, 5173\u20135180 (2021).","journal-title":"J. Cancer"},{"key":"25114_CR87","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ymthe.2019.03.019","volume":"27","author":"CC Sun","year":"2019","unstructured":"Sun, C. C. et al. Comprehensive analysis of the expression and prognosis for E2Fs in human breast cancer. Mol. Ther. 27, 1153\u20131165 (2019).","journal-title":"Mol. Ther."},{"key":"25114_CR88","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.21037\/tcr-23-34","volume":"12","author":"Z Luo","year":"2023","unstructured":"Luo, Z. et al. Cytokine-induced apoptosis inhibitor 1: A comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer. Transl. Cancer Res. 12, 1765\u20131786 (2023).","journal-title":"Transl. Cancer Res."},{"key":"25114_CR89","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12672-025-01990-w","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang, X. et al. Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer. Discov. Oncol. 16, 218 (2025).","journal-title":"Discov. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25114-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:05:08Z","timestamp":1763730308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25114-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25114"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25114-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects and their legal guardian(s). The institutional review board of Isfahan University (IR.UI.REC.1403.006) has authorized the procurement of human tissues. All experiments and procedures conducted in this study, particularly those involving human participants, adhered to the 1964 Helsinki Declaration and its subsequent amendments, or comparable ethical standards. The authors express gratitude to the volunteers for their participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"41276"}}